Concourse Financial Group Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-119
| Closed | -$80.9K | – | 6500 |
|
2024
Q4 | $80.9K | Buy |
119
+64
| +116% | +$43.5K | ﹤0.01% | 1012 |
|
2024
Q3 | $57.8K | Buy |
55
+9
| +20% | +$9.46K | ﹤0.01% | 1127 |
|
2024
Q2 | $48.3K | Buy |
46
+6
| +15% | +$6.31K | ﹤0.01% | 1184 |
|
2024
Q1 | $38.5K | Buy |
40
+12
| +43% | +$11.6K | ﹤0.01% | 1297 |
|
2023
Q4 | $24.6K | Buy |
28
+7
| +33% | +$6.15K | ﹤0.01% | 1420 |
|
2023
Q3 | $17.3K | Sell |
21
-1
| -5% | -$823 | ﹤0.01% | 1486 |
|
2023
Q2 | $15.8K | Buy |
22
+5
| +29% | +$3.59K | ﹤0.01% | 1520 |
|
2023
Q1 | $14K | Hold |
17
| – | – | ﹤0.01% | 1568 |
|
2022
Q4 | $12.3K | Buy |
17
+5
| +42% | +$3.61K | ﹤0.01% | 1585 |
|
2022
Q3 | $8K | Buy |
12
+11
| +1,100% | +$7.33K | ﹤0.01% | 1547 |
|
2022
Q2 | $1K | Sell |
1
-5
| -83% | -$5K | ﹤0.01% | 2131 |
|
2022
Q1 | $4K | Sell |
6
-279
| -98% | -$186K | ﹤0.01% | 1909 |
|
2021
Q4 | $180K | Buy |
285
+3
| +1% | +$1.9K | 0.01% | 771 |
|
2021
Q3 | $171K | Buy |
282
+36
| +15% | +$21.8K | 0.01% | 770 |
|
2021
Q2 | $137K | Sell |
246
-6
| -2% | -$3.34K | 0.01% | 853 |
|
2021
Q1 | $119K | Buy |
252
+168
| +200% | +$79.3K | 0.01% | 860 |
|
2020
Q4 | $41K | Sell |
84
-124
| -60% | -$60.5K | ﹤0.01% | 1209 |
|
2020
Q3 | $116K | Buy |
208
+147
| +241% | +$82K | 0.01% | 732 |
|
2020
Q2 | $38K | Buy |
61
+6
| +11% | +$3.74K | ﹤0.01% | 1076 |
|
2020
Q1 | $27K | Sell |
55
-10
| -15% | -$4.91K | ﹤0.01% | 1126 |
|
2019
Q4 | $24K | Buy |
+65
| New | +$24K | ﹤0.01% | 1204 |
|
2019
Q3 | – | Sell |
-75
| Closed | -$23K | – | 4759 |
|
2019
Q2 | $23K | Sell |
75
-94
| -56% | -$28.8K | ﹤0.01% | 1200 |
|
2019
Q1 | $69K | Buy |
169
+96
| +132% | +$39.2K | 0.01% | 771 |
|
2018
Q4 | $27K | Buy |
+73
| New | +$27K | ﹤0.01% | 1021 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 4478 |
|